Personal Genome Diagnostics Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy Leaders from collaborating Cleveland Clinic institutes will work with PGDx to optimize its ctDNA test reporting and adapt its technology for new oncology applications. Tesis Labs, Personal Genome Diagnostics Ink Market Access Partnership The companies are joining forces to develop new genomic tests for cancer patients that combine somatic and germline variant results. People in the News: New Appointments at Guardant Health, Foundation Medicine, PGDx, GenapSys, More People in the News: New Appointments at Castle Biosciences, Oxford Nanopore, PGDx, More Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System Under the deal, DUHS will establish PGDx's next-generation sequencing-based Elio Tissue Complete platform for the genomic profiling of cancer in its lab. Feb 25, 2021 Personal Genome Diagnostics to Build Commercial Infrastructure, Drive Partnerships With New Funding Premium Feb 19, 2021 Qiagen Launches 'Digital Partner' Program to Expand Bioinformatics Reach Feb 10, 2021 Personal Genome Diagnostics Raises $103M in Series C Financing Jan 13, 2021 PGDx, Qiagen Partner on Clinical Decision Support for Molecular Cancer Testing Jan 11, 2021 PGDx, Almac Sign Agreement to Improve Pharma Access to Tumor Profiling Assays Sep 22, 2020 Genosity Inks Comarketing Agreement with Personal Genome Diagnostics Apr 27, 2020 FDA Clears Cancer Genomic Profiling Kit From Personal Genome Diagnostics Apr 24, 2020 People in the News: Megan Bailey, Maureen Cronin, Ronald Park, Ingo Chakravarty, More Feb 10, 2020 Through Mayo Clinic Pact, PGDx Hopes to Show Clinical Utility for NGS Tissue, Liquid Biopsy Assays Premium Jan 15, 2020 PGDx, Eisai to Develop Next-Generation Sequencing Biomarker Assay Jan 8, 2020 Personal Genome Diagnostics, Mayo Clinic to Collaborate on Cancer Genomic Tests Jan 6, 2020 Guardant Health CEO Deleted Email Evidence After Lawsuit Deposition Dec 4, 2019 PGDx Gets IDE For Tissue NGS Test in Merck Immunotherapy Trial Sep 25, 2019 Personal Genome Diagnostics Gets CE Mark for Elio Tissue Complete Assay Sep 23, 2019 PGDx Shares New MSI Data, Provides Update on FDA Bid for Pan-Cancer IVDs Premium Jun 26, 2019 Allegations of Joint Defense Agreement, Funneled Documents Arise in Guardant Health Patent Suits May 16, 2019 Personal Genome Diagnostics Alleges Patent Fraud by Guardant Health in Countersuit Mar 14, 2019 PGDx Liquid Biopsy Assay Gets CE Marking Jan 7, 2019 PGDx, PathGroup to Co-Develop Genomic Profiling Assay Jan 3, 2019 PGDx Inks Agreements With KingMed, Merck for Tissue-Based TMB Testing Load More Breaking News UK Biobank Study Investigates Incomplete Penetrance of Mendelian Disease Variants MDxHealth Q3 Revenues Grow 23 Percent BioMérieux Q3 Revenues Increase 11 Percent, Firm Raises 2021 Guidance Germline Cancer Risk Genes May Hold Rhabdomyosarcoma Survival Clues, Study Suggests Danaher Q3 Revenues Rise 23 Percent, Beat Wall Street Estimates Horse Genetics Study Reveals Origins of Domestication, Use in Human Culture The Scan Guidelines for Ancient DNA Work More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature. And Cleared A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times. Suit Over Allegations The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director. Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.